1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 03/22/2023 at 12:00pm, Licensing Program Analyst (LPA) Arielle Pascua arrived to this facility unannounced to conduct a case management visit. LPA was greeted by Facility Designated Administrator (FDA), Quincy Beltran and explained the purpose of the visit. There were 3 other staff member present during the course of this visit, Anabel Contreras, Mellissa Daoud, and Mary Gonzalez. Current Census was 6.
A tour of the facility was conducted. A brief interview with FDA Beltran was conducted.
The purpose of this visit was to follow up on an incident reported received by the department on 03/16/2023. The incident report states that on 03/14/2023, the Administrator was administrating evening and night medication for the facility around 7pm and noticed that one medication was missing from the resident one (R1) bubble pack. This medication was intended to be provided in the evening and was not given the medication yet according to the medication dispensing log. The administrator conducted an internal investigation and learned that the morning staff member (S1) admitted that they provided the medication in at noon and realized after given to the resident that it was an evening medication.
Based on interviews and file review, Per California Code of Regulations (CCRs) - Title 22, Division 6, the following deficiency is being cited on the attached 809D during this visit.
An exit interview was conducted and a copy of this report, appeal rights and a copy of the confidential names list were given to the Administrator. |